Table 2.
Clinical characteristics of patients referred to supportive care services.
| Demographics | Co-morbidities | Discharge medication | Laboratory | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total number | 23 | |||||||||
| Age, years | 84 (77–88) | Hypertension | 18 (78) | ACEi/ARB | 19 (83) | BNP, pg/mL | 664 (351–1132) | |||
| Sex | Myocardial infarction | 13 (57) | Beta-blocker | 21 (91) | Na+, mmol/L | 139 (137–142) | ||||
| Male | 19 (83) | Atrial fibrillation | 13 (57) | MRA | 12 (52) | eGFR, mL/m in/1.73 m2 | 39 (25–55) | |||
| Female | 4 (17) | TIA/stroke | 4 (17) | Digoxin | 3 (13) | Hb, g/L | 118 (90–125) | |||
| SBP, mmHg | 115 (105–134) | Peripheral arterial disease | 5 (22) | |||||||
| BMI, kg/m2 | 27 (25–29) | Diabetes | 13 (57) | |||||||
| NYHA class | COPD | 12 (52) | ||||||||
| Class II | 6 (26) | Depression | 8 (35) | |||||||
| Class III | 17 (74) | Cancer | 9 (39) | |||||||
| AHA stage | ICD/CRT-D | 12 (52) | ||||||||
| Stage D | 23 (100) | |||||||||
| Years of HF Dx | 4 (2–6) | |||||||||
| ED/Hosp | 19 (83) | |||||||||
SBP, systolic blood pressure; BMI, body mass index; NYHA, New York Heart Association; AHA, American Heart Association; HF, heart failure; Dx, diagnosis; ER/Hosp, emergency department visits or hospitalization in the preceding 6 months; TIA, transient ischemic attack; COPD, chronic obstructive pulmonary disease; ICD, implantable cardioverter defibrillator; CRT-D, cardiac resynchronisation therapy defibrillator; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; MRA, mineralocorticoid receptor antagonist; BNP, B-type natriuretic peptide; Na+, sodium; eGFR, estimated glomerular filtration rate; Hb, hemoglobin.